These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 16855168)

  • 1. Effects of anti-TNF-alpha treatment on lipid profile in patients with active rheumatoid arthritis.
    Seriolo B; Paolino S; Sulli A; Fasciolo D; Cutolo M
    Ann N Y Acad Sci; 2006 Jun; 1069():414-9. PubMed ID: 16855168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone metabolism changes during anti-TNF-alpha therapy in patients with active rheumatoid arthritis.
    Seriolo B; Paolino S; Sulli A; Ferretti V; Cutolo M
    Ann N Y Acad Sci; 2006 Jun; 1069():420-7. PubMed ID: 16855169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid profile of rheumatoid arthritis patients treated with anti-tumor necrosis factor-alpha drugs changes according to disease activity and predicts clinical response.
    Cacciapaglia F; Anelli MG; Rinaldi A; Serafino L; Covelli M; Scioscia C; Iannone F; Lapadula G
    Drug Dev Res; 2014 Nov; 75 Suppl 1():S77-80. PubMed ID: 25381986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of lipoprotein plasma concentrations during long-term anti-TNF therapy in patients with active rheumatoid arthritis.
    Popa C; van den Hoogen FH; Radstake TR; Netea MG; Eijsbouts AE; den Heijer M; van der Meer JW; van Riel PL; Stalenhoef AF; Barrera P
    Ann Rheum Dis; 2007 Nov; 66(11):1503-7. PubMed ID: 17472994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short term effects of infliximab on the lipid profile in patients with rheumatoid arthritis.
    Vis M; Nurmohamed MT; Wolbink G; Voskuyl AE; de Koning M; van de Stadt R; Twisk JW; Dijkmans BA; Lems WF
    J Rheumatol; 2005 Feb; 32(2):252-5. PubMed ID: 15693084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in lipid profile during infliximab and corticosteroid treatment in rheumatoid arthritis.
    Peters MJ; Vis M; van Halm VP; Wolbink GJ; Voskuyl AE; Lems WF; Dijkmans BA; Twisk JW; de Koning MH; van de Stadt RJ; Nurmohamed MT
    Ann Rheum Dis; 2007 Jul; 66(7):958-61. PubMed ID: 17314120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conversion towards an atherogenic lipid profile in rheumatoid arthritis patients during long-term infliximab therapy.
    Dahlqvist SR; Engstrand S; Berglin E; Johnson O
    Scand J Rheumatol; 2006; 35(2):107-11. PubMed ID: 16641043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of repeated infliximab therapy on serum lipid profile in patients with refractory rheumatoid arthritis.
    Allanore Y; Kahan A; Sellam J; Ekindjian OG; Borderie D
    Clin Chim Acta; 2006 Mar; 365(1-2):143-8. PubMed ID: 16176811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modest but sustained increase of serum high density lipoprotein cholesterol levels in patients with inflammatory arthritides treated with infliximab.
    Spanakis E; Sidiropoulos P; Papadakis J; Ganotakis E; Katsikas G; Karvounaris S; Bizaki A; Kritikos H; Boumpas DT
    J Rheumatol; 2006 Dec; 33(12):2440-6. PubMed ID: 17014005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infliximab but not methotrexate induces extra-high levels of VLDL-triglyceride in patients with rheumatoid arthritis.
    Saiki O; Takao R; Naruse Y; Kuhara M; Imai S; Uda H
    J Rheumatol; 2007 Oct; 34(10):1997-2004. PubMed ID: 17787045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor necrosis factor-α inhibitor use is not associated with lipid changes in rheumatoid arthritis.
    Bili A; Morris SJ; Sartorius JA; Kirchner HL; Antohe JL; Dancea S; Wasko MC
    J Rheumatol; 2012 May; 39(5):946-8. PubMed ID: 22467937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous anti TNF-alpha antibody therapy leads to elevated triglyceride and reduced HDL-cholesterol levels in patients with rheumatoid and psoriatic arthritis.
    Cauza E; Cauza K; Hanusch-Enserer U; Etemad M; Dunky A; Kostner K
    Wien Klin Wochenschr; 2002 Dec; 114(23-24):1004-7. PubMed ID: 12635469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of anti-tumour necrosis factor therapy on cardiovascular risk factors in patients with active rheumatoid arthritis.
    Popa C; Netea MG; Radstake T; Van der Meer JW; Stalenhoef AF; van Riel PL; Barerra P
    Ann Rheum Dis; 2005 Feb; 64(2):303-5. PubMed ID: 15231512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of infliximab treatment on lipoprotein profile in patients with rheumatoid arthritis and ankylosing spondylitis.
    Kiortsis DN; Mavridis AK; Filippatos TD; Vasakos S; Nikas SN; Drosos AA
    J Rheumatol; 2006 May; 33(5):921-3. PubMed ID: 16541480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydroxychloroquine use associated with improvement in lipid profiles in rheumatoid arthritis patients.
    Morris SJ; Wasko MC; Antohe JL; Sartorius JA; Kirchner HL; Dancea S; Bili A
    Arthritis Care Res (Hoboken); 2011 Apr; 63(4):530-4. PubMed ID: 21452265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-inflammatory therapy with tumour necrosis factor alpha inhibitors improves high-density lipoprotein cholesterol antioxidative capacity in rheumatoid arthritis patients.
    Popa C; van Tits LJ; Barrera P; Lemmers HL; van den Hoogen FH; van Riel PL; Radstake TR; Netea MG; Roest M; Stalenhoef AF
    Ann Rheum Dis; 2009 Jun; 68(6):868-72. PubMed ID: 18635596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum levels of lipoprotein(a) and E-selectin are reduced in rheumatoid arthritis patients treated with methotrexate or methotrexate in combination with TNF-α-inhibitor.
    Hjeltnes G; Hollan I; Førre O; Wiik A; Lyberg T; Mikkelsen K; Agewall S
    Clin Exp Rheumatol; 2013; 31(3):415-21. PubMed ID: 23465067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Are there any positive effects of TNF-alpha blockers on bone metabolism?].
    Seriolo B; Paolino S; Sulli A; Cutolo M
    Reumatismo; 2006; 58(3):199-205. PubMed ID: 17013436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in lipoproteins associated with methotrexate or combination therapy in early rheumatoid arthritis: results from the treatment of early rheumatoid arthritis trial.
    Navarro-Millán I; Charles-Schoeman C; Yang S; Bathon JM; Bridges SL; Chen L; Cofield SS; Dell'Italia LJ; Moreland LW; O'Dell JR; Paulus HE; Curtis JR
    Arthritis Rheum; 2013 Jun; 65(6):1430-8. PubMed ID: 23460074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modifications in lipid levels are independent of serum TNF-α in rheumatoid arthritis: results of an observational 24-week cohort study comparing patients receiving etanercept plus methotrexate or methotrexate as monotherapy.
    Rodriguez-Jimenez NA; Garcia-Gonzalez CE; Ayala-Lopez KP; Trujillo-Hernandez B; Aguilar-Chavez EA; Rocha-Muñoz AD; Vasquez-Jimenez JC; Olivas-Flores E; Salazar-Paramo M; Corona-Sanchez EG; Vazquez-Del Mercado M; Varon-Villalpando E; Cota-Sanchez A; Cardona-Muñoz EG; Gamez-Nava JI; Gonzalez-Lopez L
    Biomed Res Int; 2014; 2014():510305. PubMed ID: 25243145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.